Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bay Biosciences is a private biomedical research services company and global biobank that supplies ethically sourced human biospecimens, biofluids, and associated clinical data to pharmaceutical, biotechnology, diagnostic, academic, and government researchers. The company focuses on hard-to-procure and treatment-naive specimens, especially oncology tissues, and offers customized collection protocols, pathology-supported quality control, and rapid procurement through a global network of clinical sites. Its offerings include fresh and frozen tissues, FFPE blocks, blood-derived products such as serum, plasma, and PBMCs, as well as disease-state and matched control samples across many therapeutic areas. Rather than developing proprietary therapeutics, Bay Biosciences supports translational research, biomarker discovery, assay validation, diagnostics development, and drug discovery programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bay Biosciences.